We are live on
!
Find out more
Qube Research & Technologies (QRT) Portfolio holdings
AUM
$89.9B
1-Year Est. Return
20.22%
This Fund
S&P 500
This Quarter
Est. Return
+0.34%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
–
AUM
$76.3B
AUM Growth
+$8.42B
(+12%)
Cap. Flow
+$9.49B
Cap. Flow
% of AUM
12.45%
Top 10 Holdings %
Top 10 Hldgs %
10.53%
Holding
3,927
New
717
Increased
1,476
Reduced
1,083
Closed
513
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applied Materials
AMAT
|
+$402M |
| 2 |
Johnson & Johnson
JNJ
|
+$402M |
| 3 |
Coca-Cola
KO
|
+$375M |
| 4 |
HCA Healthcare
HCA
|
+$332M |
| 5 |
Tesla
TSLA
|
+$329M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1B |
| 2 |
Microsoft
MSFT
|
+$718M |
| 3 |
Spotify
SPOT
|
+$617M |
| 4 |
Bank of America
BAC
|
+$333M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$316M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.06% |
| 2 | Consumer Discretionary | 10.91% |
| 3 | Healthcare | 10.34% |
| 4 | Financials | 10.21% |
| 5 | Industrials | 9.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Axogen
AXGN
$2.29B
| $2.43M | ﹤0.01% |
147,625
+80,690
| +121% | +$1.14M |
|
1802
Green Plains
GPRE
$1.15B
| $2.43M | ﹤0.01% |
256,477
+198,507
| +342% | +$2.24M |
|
1803
Global X US Infrastructure Development ETF
PAVE
$13.6B
| $2.43M | ﹤0.01% |
60,041
+43,549
| +264% | +$1.87M |
|
1804
Matrix Service
MTRX
$312M
| $2.41M | ﹤0.01% |
201,688
+26,006
| +15% | +$319K |
|
1805
Corvus Pharmaceuticals
CRVS
$1.1B
| $2.41M | ﹤0.01% |
450,050
+322,718
| +253% | +$2.41M |
|
1806
Bank of Hawaii
BOH
$3.15B
| $2.4M | ﹤0.01% |
33,742
-17,417
| -34% | -$1.26M |
|
1807
Takeda Pharmaceutical
TAK
$56.7B
| $2.38M | ﹤0.01% |
179,938
+49,821
| +38% | +$684K |
|
1808
Nextpower Inc
NXT
$14B
| $2.38M | ﹤0.01% |
+65,018
| New | +$2.38M |
|
1809
PUT
SolarEdge
SEDG
$2.35B
| $2.37M | ﹤0.01% |
174,400
-301,900
| -63% | -$4.65M |
|
1810
Annexon
ANNX
$791M
| $2.37M | ﹤0.01% |
461,372
+31,813
| +7% | +$196K |
|
1811
CALL
Warner Bros
WBD
$64.1B
| $2.36M | ﹤0.01% |
223,500
-10,300
| -4% | -$95.7K |
|
1812
Xperi
XPER
$366M
| $2.36M | ﹤0.01% |
229,946
-153,276
| -40% | -$1.43M |
|
1813
Supernus Pharmaceuticals
SUPN
$2.76B
| $2.35M | ﹤0.01% |
65,110
-35,854
| -36% | -$1.26M |
|
1814
PUT
Five Below
FIVE
$11.7B
| $2.35M | ﹤0.01% |
+22,400
| New | +$2.14M |
|
|
CBL
1815
CBL Properties
CBL
$1.83B
| $2.35M | ﹤0.01% |
79,936
+15,889
| +25% | +$450K |
|
|
ENFN
1816
DELISTED
Enfusion, Inc.
ENFN
| $2.34M | ﹤0.01% |
227,576
+174,960
| +333% | +$1.69M |
|
|
DAWN
1817
DELISTED
Day One Biopharmaceuticals
DAWN
| $2.34M | ﹤0.01% |
184,656
+94,468
| +105% | +$1.31M |
|
1818
Energizer
ENR
$1.48B
| $2.34M | ﹤0.01% |
+66,927
| New | +$2.31M |
|
1819
Ginkgo Bioworks
DNA
$493M
| $2.33M | ﹤0.01% |
237,646
+133,742
| +129% | +$1.15M |
|
1820
CALL
Microchip Technology
MCHP
$39.2B
| $2.32M | ﹤0.01% |
40,500
+9,200
| +29% | +$632K |
|
|
FISV
1821
CALL
Fiserv Inc
FISV
$29.6B
| $2.32M | ﹤0.01% |
11,300
-7,400
| -40% | -$1.51M |
|
1822
HF Sinclair
DINO
$16.3B
| $2.32M | ﹤0.01% |
+66,163
| New | +$2.71M |
|
1823
Magna International
MGA
$18.9B
| $2.32M | ﹤0.01% |
+55,474
| New | +$2.38M |
|
|
CHCT
1824
Community Healthcare Trust
CHCT
$541M
| $2.31M | ﹤0.01% |
120,238
-268,669
| -69% | -$4.87M |
|
1825
Grupo Cibest SA
CIB
$21.2B
| $2.31M | ﹤0.01% |
73,273
-50,195
| -41% | -$1.62M |
|
Similar funds
Qube Research & Technologies (QRT)'s Q4 2024 Portfolio in Review
As of Q4 2024, Qube Research & Technologies (QRT) held 3,927 positions worth $76.3B, up 12% from $67.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Qube Research & Technologies (QRT) deployed $9.49B of net new capital in Q4 2024, opening 717 new positions and adding to 1,476 existing holdings. Its largest new stake was Tesla: 1,023,779 shares worth $413M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was NVIDIA, an estimated $1B trimmed.
- Qube Research & Technologies (QRT)'s largest Q4 2024 buy was Tesla: 1,023,779 shares worth $413M.
- Qube Research & Technologies (QRT) added most to Applied Materials in Q4 2024, an estimated $402M increase.
- Qube Research & Technologies (QRT)'s biggest Q4 2024 reduction was NVIDIA, cutting an estimated $1B.
- Qube Research & Technologies (QRT) fully exited Honeywell in Q4 2024, selling an estimated $235M.
- Qube Research & Technologies (QRT)'s ten largest holdings make up 11% of its $76.3B portfolio in Q4 2024.
- Qube Research & Technologies (QRT) opened 717 new positions and closed 513 in Q4 2024.
- Qube Research & Technologies (QRT)'s portfolio value rose 12% quarter-over-quarter to $76.3B.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2024, filed 14 Feb 2025.